Cleaved secretory leucocyte protease inhibitor as a biomarker of chymase activity in allergic airway disease

Clinical and Experimental Allergy

Volumn 39, Issue 8, 2009, Pages 1179-1186

  Belkowski, S M ^a   Boot, J D ^b   Mascelli, M A ^c   Diamant, Z ^b   De Garavilla, L ^a   Hertzog, B ^a   Polkovitch, D ^a   Towers, M ^a   Batheja, A ^a   D'Andrea, M R ^a  

^a JOHNSON AND JOHNSON PHARMACEUTICAL RESEARCH AND DEVELOPMENT   (United States)

^b CENTRE FOR HUMAN DRUG RESEARCH   (Netherlands)

^c CENTOCOR INC   (United States)

Author keywords

Biomarker; Chymase; CSLPI; Mast cell; SLPI

Indexed keywords

ALLERGEN; ALPHA 2 MACROGLOBULIN; BIOLOGICAL MARKER; CHYMASE; CLEAVED SECRETORY LEUKOCYTE PROTEASE INHIBITOR; SECRETORY LEUKOCYTE PROTEINASE INHIBITOR; TRYPTASE; UNCLASSIFIED DRUG;

ADULT; AGED; ALLERGIC RHINITIS; ARTICLE; ASTHMA; CONTROLLED STUDY; DIAGNOSTIC VALUE; DRUG EFFICACY; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOASSAY; MAJOR CLINICAL STUDY; MALE; NOSE SECRETION; PATIENT MONITORING; PRIORITY JOURNAL; PROTEINASE INHIBITION; RESPIRATORY TRACT ALLERGY; SALIVA; SPUTUM;

ADOLESCENT; ADULT; AGED; ALPHA-MACROGLOBULINS; BIOLOGICAL MARKERS; CHYMASES; FEMALE; HUMANS; MALE; MIDDLE AGED; NASAL LAVAGE FLUID; RESPIRATORY HYPERSENSITIVITY; RETROSPECTIVE STUDIES; RHINITIS, ALLERGIC, SEASONAL; SECRETORY LEUKOCYTE PEPTIDASE INHIBITOR; SPUTUM; TRYPTASES;

EID: 67650418181     PISSN: 09547894     EISSN: 13652222     Source Type: Journal    
DOI: 10.1111/j.1365-2222.2009.03247.x     Document Type: Article

References (29)

1. Global Strategy for Asthma Management and Prevention - 2008.
2. Bousquet PJ, Combescure C, Neukirch F et al. Visual analog scales can assess the severity of rhinitis graded according to ARIA guidelines. Allergy 2007 62 : 367 72.
3. Rosi E, Ronchi MC, Grazzini M, Duranti R, Scano G. Sputum analysis, bronchial hyperresponsiveness, and airway function in asthma: results of a factor analysis. J Allergy Clin Immunol 1999 103 (Part 1) : 232 7.
4. Djukanovic R, Sterk PJ, Fahy JV, Hargreave FE. Standardised methodology of sputum induction and processing. Eur Respir J 2002 37 (Suppl.) : 1s 2s. (Pubitemid 35024260)
5. Baraldi E, de Jongste JC. Measurement of exhaled nitric oxide in children, 2001. Eur Respir J 2002 20 : 223 37.
6. Boot JD, Panzner P, Diamant Z. A critical appraisal of methods used in early clinical development of novel drugs for the treatment of asthma. Pulm Pharmacol Ther 2007 20 : 201 19.
7. Brightling CE, Bradding P, Symon FA, Holgate ST, Wardlaw AJ, Pavord ID. Mast-cell infiltration of airway smooth muscle in asthma. N Engl J Med 2002 346 : 1699 705.
8. KleinJan A, McEuen AR, Dijkstra MD, Buckley MG, Walls AF, Fokkens WJ. Basophil and eosinophil accumulation and mast cell degranulation in the nasal mucosa of patients with hay fever after local allergen provocation. J Allergy Clin Immunol 2000 106 : 677 86.
9. Zanini A, Chetta A, Saetta M et al. Chymase-positive mast cells play a role in the vascular component of airway remodeling in asthma. J Allergy Clin Immunol 2007 120 : 329 33.
10. Bousquet J, Van Cauwenberge P, Khaltaev N. Allergic rhinitis and its impact on asthma. J Allergy Clin Immunol 2001 108 (5 Suppl.) : S147 334.
11. Kay AB. Allergy and allergic diseases. Second of two parts. N Engl J Med 2001 344 : 109 13.
12. Kay AB. Allergy and allergic diseases. First of two parts. N Engl J Med 2001 344 : 30 7.
13. Al Suleimani YM, Walker MJ. Allergic rhinitis and its pharmacology. Pharmacol Ther 2007 114 : 233 60.
14. Westin U, Lundberg E, Wihl JA, Ohlsson K. The effect of immediate-hypersensitivity reactions on the level of SLPI, granulocyte elastase, alpha1-antitrypsin, and albumin in nasal secretions, by the method of unilateral antigen challenge. Allergy 1999 54 : 857 64.
15. Doumas S, Kolokotronis A, Stefanopoulos P. Anti-inflammatory and antimicrobial roles of secretory leukocyte protease inhibitor. Infect Immun 2005 73 : 1271 4.
16. Walter M, Plotnick M, Schechter NM. Inhibition of human mast cell chymase by secretory leukocyte proteinase inhibitor: enhancement of the interaction by heparin. Arch Biochem Biophys 1996 327 : 81 8.
17. Westin U, Lundberg E, Ohlsson K. IgE-mediated histamine release from nasal mucosa is inhibited by SLPI (secretory leukocyte protease inhibitor) to the level of spontaneous release. Mediators Inflamm 1998 7 : 217 20.
18. Weldon S, McGarry N, Taggart CC, McElvaney NG. The role of secretory leucoprotease inhibitor in the resolution of inflammatory responses. Biochem Soc Trans 2007 35 (Part 2) : 273 6.
19. Belkowski SM, Masucci J, Mahan A et al. Cleaved SLPI, a novel biomarker of chymase activity. Biol Chem 2008 389 : 1219 24.
20. Boot JD, de Kam ML, Mascelli MA et al. Nasal nitric oxide: longitudinal reproducibility and the effects of a nasal allergen challenge in patients with allergic rhinitis. Allergy 2007 62 : 378 84.
21. Paggiaro PL, Chanez P, Holz O et al. Sputum induction. Eur Respir J 2002 37 (Suppl.) : 3s 8s. (Pubitemid 35024261)
22. de Graaf-in't Veld C, Garrelds IM, van Toorenenbergen AW, Gerth van Wijk R. Nasal responsiveness to allergen and histamine in patients with perennial rhinitis with and without a late phase response. Thorax 1997 52 : 143 8.
23. Lebel B, Bousquet J, Morel A, Chanal I, Godard P, Michel FB. Correlation between symptoms and the threshold for release of mediators in nasal secretions during nasal challenge with grass-pollen grains. J Allergy Clin Immunol 1988 82 (Part 1) : 869 77.
24. Jacobi HH, Skov PS, Poulsen LK, Malling HJ, Mygind N. Histamine and tryptase in nasal lavage fluid after allergen challenge: effect of 1 week of pretreatment with intranasal azelastine or systemic cetirizine. J Allergy Clin Immunol 1999 103 (Part 1) : 768 72.
25. Walter M, Sutton RM, Schechter NM. Highly efficient inhibition of human chymase by alpha(2)-macroglobulin. Arch Biochem Biophys 1999 368 : 276 84.
26. Caughey GH. Of mites and men: trypsin-like proteases in the lungs. Am J Respir Cell Mol Biol 1997 16 : 621 8.
27. Bradding P, Okayama Y, Howarth PH, Church MK, Holgate ST. Heterogeneity of human mast cells based on cytokine content. J Immunol 1995 155 : 297 307.
28. Bettiol J, Radermecker M, Sele J, Henquet M, Cataldo D, Louis R. Airway mast-cell activation in asthmatics is associated with selective sputum eosinophilia. Allergy 1999 54 : 1188 93.
29. Schechter NM, Sprows JL, Schoenberger OL, Lazarus GS, Cooperman BS, Rubin H. Reaction of human skin chymotrypsin-like proteinase chymase with plasma proteinase inhibitors. J Biol Chem 1989 264 : 21308 15.